Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
464.60
+7.00 (1.53%)
Last updated: Mar 30, 2026, 11:58 AM HKT

HKG:6990 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,2441,3371,52992.9681.79
Short-Term Investments
292.57283.98325.87--
Trading Asset Securities
935.311,448633.71--
Cash & Short-Term Investments
4,4723,0692,48892.9681.79
Cash Growth
45.71%23.33%2576.80%13.65%-
Accounts Receivable
97.2760.761.3561.822.73
Other Receivables
193.42183.33123.142.6347.83
Receivables
290.69244.09124.45104.4370.56
Inventory
240.94110.5163.0352.6450.72
Prepaid Expenses
-2.0935.65--
Other Current Assets
145.3267.3396.0182.2995.27
Total Current Assets
5,1493,4932,807332.32298.34
Property, Plant & Equipment
758.5758.11692.73647.82474.17
Long-Term Investments
70.08----
Other Intangible Assets
1.12.581.343.180.49
Other Long-Term Assets
10.2314.518.29.8339.97
Total Assets
5,9894,2683,510993.15812.96
Accounts Payable
426.45291.29404.38327.46325.28
Accrued Expenses
184.53156.34133.7786.6144.72
Short-Term Debt
---2,8912,388
Current Portion of Leases
44.441.8454.4182.261.66
Current Income Taxes Payable
105.463.732.72.52
Current Unearned Revenue
258.03312.38510.69163.98109.04
Other Current Liabilities
81.082.543.03613.57573.72
Total Current Liabilities
1,004809.841,1104,1673,445
Long-Term Leases
44.0484.915.5141.291.25
Long-Term Unearned Revenue
72.9464.664.7410.6810.68
Total Liabilities
1,121959.341,1804,2193,457
Common Stock
233.19227.27219.2107.37107.37
Retained Earnings
-4,705-4,323-4,056-3,482-2,866
Comprehensive Income & Other
9,3397,4046,167148.63114.83
Shareholders' Equity
4,8673,3092,329-3,226-2,644
Total Liabilities & Equity
5,9894,2683,510993.15812.96
Total Debt
88.44126.7559.923,0142,391
Net Cash (Debt)
4,3832,9422,428-2,921-2,309
Net Cash Growth
48.99%21.15%---
Net Cash Per Share
19.0113.2713.22-30.58-24.98
Filing Date Shares Outstanding
233.19227.27219.2215.8392.46
Total Common Shares Outstanding
233.19227.27219.2107.3792.46
Working Capital
4,1442,6831,697-3,835-3,147
Book Value Per Share
20.8714.5610.63-30.05-28.60
Tangible Book Value
4,8663,3062,328-3,229-2,644
Tangible Book Value Per Share
20.8714.5510.62-30.08-28.60
Buildings
-294.1294.4--
Machinery
-324.51262.26221.56200.16
Construction In Progress
-88.11119.99348.59282.36
Leasehold Improvements
-16.4714.4513.670.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.